
LINK . SPRINGER . COM {
}
Title:
TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5 | Journal of Molecular Medicine
Description:
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and agonistic anti-DR4/TRAIL-R1 and anti-DR5/TRAIL-R2 antibodies are currently under clinical investigation for treatment of different malignancies. TRAIL activates DR4 and DR5 and thereby triggers apoptotic and non-apoptotic signaling pathways, but possible different roles of DR4 or DR5 in these responses has poorly been addressed so far. In the present work, we analyzed cell viability, DISC formation as well as IL-8 and NF–κB activation side by side in responses to TRAIL and agonistic antibodies against DR4 (mapatumumab) and against DR5 (lexatumumab) in pancreatic ductal adenocarcinoma cells. We found that all three reagents are able to activate cell death and pro-inflammatory signaling. Death-inducing signaling complex (DISC) analysis revealed that mapatumumab and lexatumumab induce formation of homocomplexes of either DR4 or DR5, whereas TRAIL additionally stimulated the formation of heterocomplexes of both receptors. Notably, blocking of receptors using DR4- and DR5-specific Fab fragments indicated that TRAIL exerted its function predominantly via DR4. Interestingly, inhibition of PKC by Goe6983 enabled DR5 to trigger apoptotic signaling in response to TRAIL and also strongly enhanced lexatumumab-mediated cell death. Our results suggest the existence of mechanisms that silence DR5 for TRAIL- but not for agonistic-antibody treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, google, scholar, cas, pubmed, trail, receptor, signaling, apoptosis, cells, tumor, cell, death, cancer, pancreatic, trauzold, ligand, biol, lee, necrosis, apoptosisinducing, trailr, factorrelated, kalthoff, activation, receptors, human, park, oncogene, privacy, cookies, content, journal, molecular, wajant, adenocarcinoma, access, walczak, roder, protein, data, information, publish, research, search, medicine, lemke, adam, related, antibodies,
Topics {✒️}
month download article/chapter death-inducing signaling complex anti-dr5/trail-r2 antibodies proapoptotic ligand apo2l/trail agonistic anti-dr4/trail-r1 trail-receptor-mediated apoptosis pancreatic tumor cells trail-mediated dr5-disc formation drug-induced apoptosis trail-induced apoptosis trail-receptor-specific antibodies related regulatory pathways dr5-specific fab fragments nf–κb activation side cytotoxic ligand trail p53 tumor suppressor apoptosis-mediating receptor fadd-binding death receptors related subjects full article pdf tumor-derived mutations pancreatic cancer cells molecular medicine aims molecular internal medicine pancreatic tumour cells pancreatic carcinoma cells privacy choices/manage cookies experimental cancer research apoptosis-controlling genes receptor-selective mutants ligand binding death receptor signaling agonistic-antibody treatment human genome sciences lexatumumab induce formation degli-esposti ma electronic supplementary material activate cell death death signaling vesicles apoptotic signaling pathways trigger apoptotic signaling analyzed cell viability alternatively spliced receptor pro-inflammatory signaling survival signaling leads dfg grants schu733/7-1 internal medicine ii killer/dr5 gene functional binding sites apoptosis signaling
Questions {❓}
- Newsom-Davis T, Prieske S, Walczak H (2009) Is TRAIL the holy grail of cancer therapy?
Schema {🗺️}
WebPage:
mainEntity:
headline:TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
description:Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and agonistic anti-DR4/TRAIL-R1 and anti-DR5/TRAIL-R2 antibodies are currently under clinical investigation for treatment of different malignancies. TRAIL activates DR4 and DR5 and thereby triggers apoptotic and non-apoptotic signaling pathways, but possible different roles of DR4 or DR5 in these responses has poorly been addressed so far. In the present work, we analyzed cell viability, DISC formation as well as IL-8 and NF–κB activation side by side in responses to TRAIL and agonistic antibodies against DR4 (mapatumumab) and against DR5 (lexatumumab) in pancreatic ductal adenocarcinoma cells. We found that all three reagents are able to activate cell death and pro-inflammatory signaling. Death-inducing signaling complex (DISC) analysis revealed that mapatumumab and lexatumumab induce formation of homocomplexes of either DR4 or DR5, whereas TRAIL additionally stimulated the formation of heterocomplexes of both receptors. Notably, blocking of receptors using DR4- and DR5-specific Fab fragments indicated that TRAIL exerted its function predominantly via DR4. Interestingly, inhibition of PKC by Goe6983 enabled DR5 to trigger apoptotic signaling in response to TRAIL and also strongly enhanced lexatumumab-mediated cell death. Our results suggest the existence of mechanisms that silence DR5 for TRAIL- but not for agonistic-antibody treatment.
datePublished:2010-03-31T00:00:00Z
dateModified:2010-03-31T00:00:00Z
pageStart:729
pageEnd:740
sameAs:https://doi.org/10.1007/s00109-010-0619-0
keywords:
TRAIL
DR4/DR5
Mapatumumab
Lexatumumab
Pancreatic adenocarcinoma
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig8_HTML.gif
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:88
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Johannes Lemke
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Andreas Noack
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Dieter Adam
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Vladimir Tchikov
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Uwe Bertsch
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Christian Röder
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Stefan Schütze
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Harald Wajant
affiliation:
name:University Hospital Würzburg
address:
name:Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Holger Kalthoff
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Anna Trauzold
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
description:Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and agonistic anti-DR4/TRAIL-R1 and anti-DR5/TRAIL-R2 antibodies are currently under clinical investigation for treatment of different malignancies. TRAIL activates DR4 and DR5 and thereby triggers apoptotic and non-apoptotic signaling pathways, but possible different roles of DR4 or DR5 in these responses has poorly been addressed so far. In the present work, we analyzed cell viability, DISC formation as well as IL-8 and NF–κB activation side by side in responses to TRAIL and agonistic antibodies against DR4 (mapatumumab) and against DR5 (lexatumumab) in pancreatic ductal adenocarcinoma cells. We found that all three reagents are able to activate cell death and pro-inflammatory signaling. Death-inducing signaling complex (DISC) analysis revealed that mapatumumab and lexatumumab induce formation of homocomplexes of either DR4 or DR5, whereas TRAIL additionally stimulated the formation of heterocomplexes of both receptors. Notably, blocking of receptors using DR4- and DR5-specific Fab fragments indicated that TRAIL exerted its function predominantly via DR4. Interestingly, inhibition of PKC by Goe6983 enabled DR5 to trigger apoptotic signaling in response to TRAIL and also strongly enhanced lexatumumab-mediated cell death. Our results suggest the existence of mechanisms that silence DR5 for TRAIL- but not for agonistic-antibody treatment.
datePublished:2010-03-31T00:00:00Z
dateModified:2010-03-31T00:00:00Z
pageStart:729
pageEnd:740
sameAs:https://doi.org/10.1007/s00109-010-0619-0
keywords:
TRAIL
DR4/DR5
Mapatumumab
Lexatumumab
Pancreatic adenocarcinoma
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_Fig8_HTML.gif
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:88
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Johannes Lemke
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Andreas Noack
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Dieter Adam
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Vladimir Tchikov
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Uwe Bertsch
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Christian Röder
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Stefan Schütze
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Harald Wajant
affiliation:
name:University Hospital Würzburg
address:
name:Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Holger Kalthoff
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
type:Person
name:Anna Trauzold
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:88
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
name:University Hospital Würzburg
address:
name:Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
type:PostalAddress
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Johannes Lemke
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Andreas Noack
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Dieter Adam
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Vladimir Tchikov
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Uwe Bertsch
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Christian Röder
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Stefan Schütze
affiliation:
name:UK S-H
address:
name:Institute of Immunology, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Harald Wajant
affiliation:
name:University Hospital Würzburg
address:
name:Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
type:PostalAddress
type:Organization
name:Holger Kalthoff
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
name:Anna Trauzold
affiliation:
name:UK S-H
address:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
name:Institute of Immunology, UK S-H, Kiel, Germany
name:Institute of Immunology, UK S-H, Kiel, Germany
name:Institute of Immunology, UK S-H, Kiel, Germany
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
name:Institute of Immunology, UK S-H, Kiel, Germany
name:Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
name:Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Kiel, Germany
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(143)
- https://www.springernature.com/gp/authors's revenue stream
- What's the profit of https://link.springernature.com/home/?
- https://order.springer.com/public/cart's financial summary
- How much profit is https://www.editorialmanager.com/jmme making per month?
- Check the income stats for https://www.springernature.com/gp/librarians/licensing/agc/journals
- Earnings of https://doi.org/10.1038%2F5517
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9930862
- How much income does http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis%20inducing%20ligand%20in%20vivo&journal=Nat%20Med&doi=10.1038%2F5517&volume=5&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM&author=Chin%2CW&author=Jones%2CJ&author=Woodward%2CA&author=Le%2CT have?
- How profitable is https://doi.org/10.1126%2Fscience.276.5309.111?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9082980?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20receptor%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=Science&doi=10.1126%2Fscience.276.5309.111&volume=276&pages=111-113&publication_year=1997&author=Pan%2CG&author=O%27Rourke%2CK&author=Chinnaiyan%2CAM&author=Gentz%2CR&author=Ebner%2CR&author=Ni%2CJ&author=Dixit%2CVM generate?
- What is the earnings of https://doi.org/10.1016%2FS0014-5793%2897%2901231-3?
- How much money does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20two%20receptors%20for%20TRAIL&journal=FEBS%20let&doi=10.1016%2FS0014-5793%2897%2901231-3&volume=416&pages=329-334&publication_year=1997&author=Schneider%2CP&author=Bodmer%2CJL&author=Thome%2CM&author=Hofmann%2CK&author=Holler%2CN&author=Tschopp%2CJ make?
- How much does https://doi.org/10.1126%2Fscience.277.5327.815 pull in?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9242610?
- How profitable is http://scholar.google.com/scholar_lookup?&title=An%20antagonist%20decoy%20receptor%20and%20a%20death%20domain-containing%20receptor%20for%20TRAIL&journal=Science&doi=10.1126%2Fscience.277.5327.815&volume=277&pages=815-818&publication_year=1997&author=Pan%2CG&author=Ni%2CJ&author=Wei%2CYF&author=Yu%2CG&author=Gentz%2CR&author=Dixit%2CVM?
- Income figures for https://doi.org/10.1093%2Femboj%2F16.17.5386
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9311998?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=TRAIL-R2%3A%20a%20novel%20apoptosis-mediating%20receptor%20for%20TRAIL&journal=EMBO%20J&doi=10.1093%2Femboj%2F16.17.5386&volume=16&pages=5386-5397&publication_year=1997&author=Walczak%2CH&author=Degli-Esposti%2CMA&author=Johnson%2CRS&author=Smolak%2CPJ&author=Waugh%2CJY&author=Boiani%2CN&author=Timour%2CMS&author=Gerhart%2CMJ&author=Schooley%2CKA&author=Smith%2CCA
- What's the income generated by https://doi.org/10.1016%2FS0960-9822%2806%2900297-1 each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9285725 net monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=TRICK2%2C%20a%20new%20alternatively%20spliced%20receptor%20that%20transduces%20the%20cytotoxic%20signal%20from%20TRAIL&journal=Curr%20Biol&doi=10.1016%2FS0960-9822%2806%2900297-1&volume=7&pages=693-696&publication_year=1997&author=Screaton%2CGR&author=Mongkolsapaya%2CJ&author=Xu%2CXN&author=Cowper%2CAE&author=McMichael%2CAJ&author=Bell%2CJI?
- How much income does https://doi.org/10.1016%2Fj.biocel.2007.02.007 have?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17403612
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=TRAIL%20signalling%3A%20decisions%20between%20life%20and%20death&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2Fj.biocel.2007.02.007&volume=39&pages=1462-1475&publication_year=2007&author=Falschlehner%2CC&author=Emmerich%2CCH&author=Gerlach%2CB&author=Walczak%2CH?
- What is the earnings of https://doi.org/10.1158%2F1078-0432.CCR-07-0251?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17545549's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Bortezomib%20sensitizes%20primary%20human%20astrocytoma%20cells%20of%20WHO%20grades%20I%20to%20IV%20for%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand-induced%20apoptosis&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-0251&volume=13&pages=3403-3412&publication_year=2007&author=Koschny%2CR&author=Holland%2CH&author=Sykora%2CJ&author=Haas%2CTL&author=Sprick%2CMR&author=Ganten%2CTM&author=Krupp%2CW&author=Bauer%2CM&author=Ahnert%2CP&author=Meixensberger%2CJ earn?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19194800 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Is%20TRAIL%20the%20holy%20grail%20of%20cancer%20therapy%3F&journal=Apoptosis&doi=10.1007%2Fs10495-009-0321-2&volume=14&pages=607-623&publication_year=2009&author=Newsom-Davis%2CT&author=Prieske%2CS&author=Walczak%2CH earn?
- Find out how much https://doi.org/10.1074%2Fjbc.M704210200 earns monthly
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17666396?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Tumor-derived%20mutations%20in%20the%20TRAIL%20receptor%20DR5%20inhibit%20TRAIL%20signaling%20through%20the%20DR4%20receptor%20by%20competing%20for%20ligand%20binding&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M704210200&volume=282&pages=28189-28194&publication_year=2007&author=Bin%2CL&author=Thorburn%2CJ&author=Thomas%2CLR&author=Clark%2CPE&author=Humphreys%2CR&author=Thorburn%2CA
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11431320
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Mutations%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20receptor%201%20%28TRAIL-R1%29%20and%20receptor%202%20%28TRAIL-R2%29%20genes%20in%20metastatic%20breast%20cancers&journal=Cancer%20Res&volume=61&pages=4942-4946&publication_year=2001&author=Shin%2CMS&author=Kim%2CHS&author=Lee%2CSH&author=Park%2CWS&author=Kim%2CSY&author=Park%2CJY&author=Lee%2CJH&author=Lee%2CSK&author=Lee%2CSN&author=Jung%2CSS each month?
- See how much https://doi.org/10.1053%2Fgast.2001.28663 makes per month
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11677215?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Inactivating%20mutations%20of%20KILLER%2FDR5%20gene%20in%20gastric%20cancers&journal=Gastroenterology&doi=10.1053%2Fgast.2001.28663&volume=121&pages=1219-1225&publication_year=2001&author=Park%2CWS&author=Lee%2CJH&author=Shin%2CMS&author=Park%2CJY&author=Kim%2CHS&author=Kim%2CYS&author=Park%2CCH&author=Lee%2CSK&author=Lee%2CSH&author=Lee%2CSN earns monthly
- Profit of https://doi.org/10.1038%2Fsj.onc.1203816
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11030149 bring in each month?
- See how much http://scholar.google.com/scholar_lookup?&title=Resistance%20to%20TRAIL-induced%20apoptosis%20in%20primitive%20neuroectodermal%20brain%20tumor%20cells%20correlates%20with%20a%20loss%20of%20caspase-8%20expression&journal=Oncogene&doi=10.1038%2Fsj.onc.1203816&volume=19&pages=4604-4610&publication_year=2000&author=Grotzer%2CMA&author=Eggert%2CA&author=Zuzak%2CTJ&author=Janss%2CAJ&author=Marwaha%2CS&author=Wiewrodt%2CBR&author=Ikegaki%2CN&author=Brodeur%2CGM&author=Phillips%2CPC makes per month
- Earnings of https://doi.org/10.1038%2Fsj.onc.1204750
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11593392?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Sensitization%20for%20death%20receptor-%20or%20drug-induced%20apoptosis%20by%20re-expression%20of%20caspase-8%20through%20demethylation%20or%20gene%20transfer&journal=Oncogene&doi=10.1038%2Fsj.onc.1204750&volume=20&pages=5865-5877&publication_year=2001&author=Fulda%2CS&author=Kufer%2CMU&author=Meyer%2CE&author=Valen%2CF&author=Dockhorn-Dworniczak%2CB&author=Debatin%2CKM earns monthly
- How much does https://doi.org/10.1038%2Fsj.onc.1204559 net monthly?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11464292?
- How much money does http://scholar.google.com/scholar_lookup?&title=CD95%20and%20TRAIL%20receptor-%20mediated%20activation%20of%20protein%20kinase%20C%20and%20NF%E2%80%93kappaB%20contributes%20to%20apoptosis%20resistance%20in%20ductal%20pancreatic%20adenocarcinoma%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1204559&volume=20&pages=4258-4269&publication_year=2001&author=Trauzold%2CA&author=Wermann%2CH&author=Arlt%2CA&author=Schutze%2CS&author=Schafer%2CH&author=Oestern%2CS&author=Roder%2CC&author=Ungefroren%2CH&author=Lampe%2CE&author=Heinrich%2CM make?
- What's the monthly money flow for https://doi.org/10.1016%2Fj.ceb.2005.09.010?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16226446 earns monthly
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Nonapoptotic%20functions%20of%20FADD-binding%20death%20receptors%20and%20their%20signaling%20molecules&journal=Curr%20Opin%20Cell%20Biol&doi=10.1016%2Fj.ceb.2005.09.010&volume=17&pages=610-616&publication_year=2005&author=Park%2CSM&author=Schickel%2CR&author=Peter%2CME?
- How much cash flow does https://doi.org/10.1002%2Fjcp.20099 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15389537 earn?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Emerging%20non-apoptotic%20functions%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%2FApo2L&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.20099&volume=201&pages=331-340&publication_year=2004&author=Pietro%2CR&author=Zauli%2CG?
- https://doi.org/10.1016%2Fj.cellsig.2006.12.008 income
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17291719
- How much does http://scholar.google.com/scholar_lookup?&title=Role%20of%20caspases%20in%20CD95L-%20and%20TRAIL-induced%20non-apoptotic%20signalling%20in%20pancreatic%20tumour%20cells&journal=Cell%20Signal&doi=10.1016%2Fj.cellsig.2006.12.008&volume=19&pages=1172-1184&publication_year=2007&author=Siegmund%2CD&author=Klose%2CS&author=Zhou%2CD&author=Baumann%2CB&author=Roder%2CC&author=Kalthoff%2CH&author=Wajant%2CH&author=Trauzold%2CA gross monthly?
- Financial intake of https://doi.org/10.1038%2Fsj.onc.1203936
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11114725
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Bcl-XL%20protects%20pancreatic%20adenocarcinoma%20cells%20against%20CD95-%20and%20TRAIL-receptor-mediated%20apoptosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203936&volume=19&pages=5477-5486&publication_year=2000&author=Hinz%2CS&author=Trauzold%2CA&author=Boenicke%2CL&author=Sandberg%2CC&author=Beckmann%2CS&author=Bayer%2CE&author=Walczak%2CH&author=Kalthoff%2CH&author=Ungefroren%2CH bring in?
- Learn how profitable https://doi.org/10.1038%2Fsj.bjc.6601330 is on a monthly basis
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14583775
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Multiple%20and%20synergistic%20deregulations%20of%20apoptosis-controlling%20genes%20in%20pancreatic%20carcinoma%20cells&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6601330&volume=89&pages=1714-1721&publication_year=2003&author=Trauzold%2CA&author=Schmiedel%2CS&author=Roder%2CC&author=Tams%2CC&author=Christgen%2CM&author=Oestern%2CS&author=Arlt%2CA&author=Westphal%2CS&author=Kapischke%2CM&author=Ungefroren%2CH?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15670977
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=CD95%20and%20TRAF2%20promote%20invasiveness%20of%20pancreatic%20cancer%20cells&journal=Faseb%20J&volume=19&pages=620-622&publication_year=2005&author=Trauzold%2CA&author=Roder%2CC&author=Sipos%2CB&author=Karsten%2CK&author=Arlt%2CA&author=Jiang%2CP&author=Martin-Subero%2CJI&author=Siegmund%2CD&author=Muerkoster%2CS&author=Pagerols-Raluy%2CL each month?
- What's the revenue for https://doi.org/10.1038%2Fsj.onc.1209719?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16751802
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=TRAIL%20promotes%20metastasis%20of%20human%20pancreatic%20ductal%20adenocarcinoma&journal=Oncogene&doi=10.1038%2Fsj.onc.1209719&volume=25&pages=7434-7439&publication_year=2006&author=Trauzold%2CA&author=Siegmund%2CD&author=Schniewind%2CB&author=Sipos%2CB&author=Egberts%2CJ&author=Zorenkov%2CD&author=Emme%2CD&author=Roder%2CC&author=Kalthoff%2CH&author=Wajant%2CH
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18437894?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Trail%20receptors%3A%20targets%20for%20cancer%20therapy&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-1-4020-6554-5_7&volume=615&pages=127-158&publication_year=2008&author=Humphreys%2CRC&author=Halpern%2CW
- How much does https://doi.org/10.1016%2Fj.immuni.2004.08.017 gross monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15357952 produce monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Compartmentalization%20of%20TNF%20receptor%201%20signaling%3A%20internalized%20TNF%20receptosomes%20as%20death%20signaling%20vesicles&journal=Immunity&doi=10.1016%2Fj.immuni.2004.08.017&volume=21&pages=415-428&publication_year=2004&author=Schneider-Brachert%2CW&author=Tchikov%2CV&author=Neumeyer%2CJ&author=Jakob%2CM&author=Winoto-Morbach%2CS&author=Held-Feindt%2CJ&author=Heinrich%2CM&author=Merkel%2CO&author=Ehrenschwender%2CM&author=Adam%2CD?
- What are the total earnings of https://doi.org/10.1074%2Fjbc.272.43.26953?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9341131 make?
- http://scholar.google.com/scholar_lookup?&title=FLICE%20is%20predominantly%20expressed%20as%20two%20functionally%20active%20isoforms%2C%20caspase-8%2Fa%20and%20caspase-8%2Fb&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.272.43.26953&volume=272&pages=26953-26958&publication_year=1997&author=Scaffidi%2CC&author=Medema%2CJP&author=Krammer%2CPH&author=Peter%2CME's revenue stream
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1431095 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20monoclonal%20antibody%20anti-APO-1%20class%20switch%20variants%20is%20dependent%20on%20cross-linking%20of%20APO-1%20cell%20surface%20antigens&journal=J%20Immunol&volume=149&pages=3166-3173&publication_year=1992&author=Dhein%2CJ&author=Daniel%2CPT&author=Trauth%2CBC&author=Oehm%2CA&author=M%C3%B6ller%2CP&author=Krammer%2CPH make?
- How much income does https://doi.org/10.1016%2FS0014-5793%2898%2901109-0 have?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20promoter%20of%20human%20p22%2FPACAP%20response%20gene%201%20%28PRG1%29%20contains%20functional%20binding%20sites%20for%20the%20p53%20tumor%20suppressor%20and%20for%20NF%E2%80%93kappaB&journal=FEBS%20let&doi=10.1016%2FS0014-5793%2898%2901109-0&volume=436&pages=139-143&publication_year=1998&author=Schafer%2CH&author=Diebel%2CJ&author=Arlt%2CA&author=Trauzold%2CA&author=Schmidt%2CWE bring in each month?
- How much money does https://doi.org/10.1074%2Fjbc.M410660200 generate?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15520016's gross income?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Receptor-selective%20mutants%20of%20apoptosis-inducing%20ligand%202%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20reveal%20a%20greater%20contribution%20of%20death%20receptor%20%28DR%29%205%20than%20DR4%20to%20apoptosis%20signaling&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M410660200&volume=280&pages=2205-2212&publication_year=2005&author=Kelley%2CRF&author=Totpal%2CK&author=Lindstrom%2CSH&author=Mathieu%2CM&author=Billeci%2CK&author=Deforge%2CL&author=Pai%2CR&author=Hymowitz%2CSG&author=Ashkenazi%2CA bring in?
- What's the financial outcome of https://doi.org/10.1038%2Fsj.cdd.4401649?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Chronic%20lymphocytic%20leukemic%20cells%20exhibit%20apoptotic%20signaling%20via%20TRAIL-R1&journal=Cell%20Ceath%20Differ&doi=10.1038%2Fsj.cdd.4401649&volume=12&pages=773-782&publication_year=2005&author=MacFarlane%2CM&author=Inoue%2CS&author=Kohlhaas%2CSL&author=Majid%2CA&author=Harper%2CN&author=Kennedy%2CDB&author=Dyer%2CMJ&author=Cohen%2CGM?
- How much money does https://doi.org/10.1038%2Fsj.onc.1204558 make?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11494138's earnings
- What's http://scholar.google.com/scholar_lookup?&title=Differential%20activation%20of%20TRAIL-R1%20and%20-2%20by%20soluble%20and%20membrane%20TRAIL%20allows%20selective%20surface%20antigen-directed%20activation%20of%20TRAIL-R2%20by%20a%20soluble%20TRAIL%20derivative&journal=Oncogene&doi=10.1038%2Fsj.onc.1204558&volume=20&pages=4101-4106&publication_year=2001&author=Wajant%2CH&author=Moosmayer%2CD&author=Wuest%2CT&author=Bartke%2CT&author=Gerlach%2CE&author=Schonherr%2CU&author=Peters%2CN&author=Scheurich%2CP&author=Pfizenmaier%2CK's gross income?
- How much does https://doi.org/10.1128%2FMCB.00520-06 bring in each month?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16980609 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Differential%20inhibition%20of%20TRAIL-mediated%20DR5-DISC%20formation%20by%20decoy%20receptors%201%20and%202&journal=Mol%20Cell%20Biol&doi=10.1128%2FMCB.00520-06&volume=26&pages=7046-7055&publication_year=2006&author=Merino%2CD&author=Lalaoui%2CN&author=Morizot%2CA&author=Schneider%2CP&author=Solary%2CE&author=Micheau%2CO make?
- What's the financial outcome of https://doi.org/10.1038%2Fnm1627?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17767167 pull in monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Death-receptor%20O-glycosylation%20controls%20tumor-cell%20sensitivity%20to%20the%20proapoptotic%20ligand%20Apo2L%2FTRAIL&journal=Nat%20Med&doi=10.1038%2Fnm1627&volume=13&pages=1070-1077&publication_year=2007&author=Wagner%2CKW&author=Punnoose%2CEA&author=Januario%2CT&author=Lawrence%2CDA&author=Pitti%2CRM&author=Lancaster%2CK&author=Lee%2CD&author=Goetz%2CM&author=Yee%2CSF&author=Totpal%2CK generate?
- What's the monthly money flow for https://doi.org/10.1158%2F0008-5472.CAN-04-2749?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16140950
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Protein%20kinase%20C%20inhibition%20and%20x-linked%20inhibitor%20of%20apoptosis%20protein%20degradation%20contribute%20to%20the%20sensitization%20effect%20of%20luteolin%20on%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand-induced%20apoptosis%20in%20cancer%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-2749&volume=65&pages=7815-7823&publication_year=2005&author=Shi%2CRX&author=Ong%2CCN&author=Shen%2CHM?
- Monthly income for https://doi.org/10.1074%2Fjbc.M307376200
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12920112?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Protein%20kinase%20C%20modulates%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand-induced%20apoptosis%20by%20targeting%20the%20apical%20events%20of%20death%20receptor%20signaling&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M307376200&volume=278&pages=44338-44347&publication_year=2003&author=Harper%2CN&author=Hughes%2CMA&author=Farrow%2CSN&author=Cohen%2CGM&author=MacFarlane%2CM
- How much does https://doi.org/10.1038%2Fsj.cdd.4400791 pull in?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11313719?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Activation%20of%20protein%20kinase%20C%20inhibits%20TRAIL-induced%20caspases%20activation%2C%20mitochondrial%20events%20and%20apoptosis%20in%20a%20human%20leukemic%20T%20cell%20line&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4400791&volume=8&pages=172-181&publication_year=2001&author=Sarker%2CM&author=Ruiz-Ruiz%2CC&author=Lopez-Rivas%2CA
- Income figures for https://citation-needed.springer.com/v2/references/10.1007/s00109-010-0619-0?format=refman&flavour=references
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Johannes%20Lemke bring in each month?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Johannes%20Lemke%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andreas%20Noack?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andreas%20Noack%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dieter%20Adam?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dieter%20Adam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vladimir%20Tchikov?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vladimir%20Tchikov%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Uwe%20Bertsch
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Uwe%20Bertsch%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christian%20R%C3%B6der net monthly?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christian%20R%C3%B6der%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stefan%20Sch%C3%BCtze
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stefan%20Sch%C3%BCtze%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Harald%20Wajant's revenue stream
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Harald%20Wajant%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Holger%20Kalthoff make?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Holger%20Kalthoff%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anna%20Trauzold produce monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anna%20Trauzold%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the total earnings of http://dx.doi.org/10.1007/s00109-011-0738-2?
- What's the revenue for https://static-content.springer.com/esm/art%3A10.1007%2Fs00109-010-0619-0/MediaObjects/109_2010_619_MOESM1_ESM.doc?
- https://s100.copyright.com/AppDispatchServlet?title=TRAIL%20signaling%20is%20mediated%20by%20DR4%20in%20pancreatic%20tumor%20cells%20despite%20the%20expression%20of%20functional%20DR5&author=Johannes%20Lemke%20et%20al&contentID=10.1007%2Fs00109-010-0619-0©right=Springer-Verlag&publication=0946-2716&publicationDate=2010-03-31&publisherName=SpringerNature&orderBeanReset=true income
- What's the monthly income of https://citation-needed.springer.com/v2/references/10.1007/s00109-010-0619-0?format=refman&flavour=citation?
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's revenue stream
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research rake in every month?
- How profitable is https://www.springernature.com/gp/products?
- How much does https://www.springernature.com/gp/librarians pull in monthly?
- Check the income stats for https://www.springernature.com/gp/societies
- Income figures for https://www.springernature.com/gp/partners
- Earnings of https://www.springer.com/
- What are the total earnings of https://www.nature.com/?
- How much income does https://www.biomedcentral.com/ have?
- How much does https://www.palgrave.com/ pull in?
- How much money does https://www.apress.com/ make?
- Earnings of https://www.springernature.com/gp/legal/ccpa
- https://www.springernature.com/gp/info/accessibility's financial summary
- What is the earnings of https://support.springernature.com/en/support/home?
- How much income is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earning monthly?
- https://www.springernature.com/ income
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref